Irbesartan Tablet
Product Images NDC 72162-2355

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 72162-2355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622355)

This is a label for Irbesartan Tablets, USP, each containing 150 mg of irbesartan. The label specifies storage conditions at 20° to 25°C (68° to 77°F) with permitted excursions and protection from light. It is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd. The package contains 30 tablets and is marked Rx only with the NDC 72162-2355.*

FDA Label Image

Structure (Spl Image1 Structure)

Chemical structure of Irbesartan, showing its molecular arrangement including rings and functional groups typical of this active pharmaceutical ingredient.*

FDA Label Image

Figure 1 (Spl Image2 Figure1)

A scatter plot with a curve fit illustrating the relationship between Irbesartan dose (mg/day) on the x-axis and the placebo-subtracted reduction in trough SeSBP (mmHg) on the y-axis. The data points show variability with an overall increasing trend plateauing at higher doses.*

FDA Label Image

Figure 2 (Spl Image3 Figure2)

A scatterplot with a curve depicting the placebo-subtracted reduction in trough SeDBP (systolic blood pressure) versus Irbesartan dose in mg/day. The x-axis ranges from 0 to 900 mg/day, and the y-axis ranges from -2 to 8 mmHg, showing dose-response data points and a fitted curve.*

FDA Label Image

Figure 3 (Spl Image4 Figure3)

A line chart depicting cumulative event rates (%) over months of follow-up for three groups: Irbesartan, Amlodipine, and Placebo. The chart includes a legend comparing Irbesartan to Placebo and Amlodipine, showing relative risk (RR) and p-values. Irbesartan shows a lower cumulative event rate compared to the other groups over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.